Redhill Biopharma LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
YA II PN, Ltd. and its affiliates disclosed a 9.9% beneficial ownership stake in RedHill Biopharma Ltd. following a Standby Equity Distribution Agreement.
NASDAQ
Alumni Capital LP, its general partner, and manager have jointly filed a Schedule 13G, disclosing beneficial ownership of 9.99% of RedHill Biopharma Ltd.'s American Depository Shares.